 Evelo Biosciences EVLO, a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that it will host a conference call and live webcast at 8:30 a.m. EST on Thursday, February 13, 2020 to report its fourth quarter and full year 2019 financial results and discuss business highlights. A live webcast of the event will also be available under News and Events in the Investors section of Evelos website at The archived webcast will be available on Evelos website approximately two hours after the completion of the event and will be available for 30 days following the call. 